This inventor holds 1 USPTO granted patent. Top assignees: Case Western Reserve University, The Cleveland Clinic Foundation, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2026.
Company Filing History:
1 out of 1,363 
1 out of 1,071 
1 out of 955 
Years Active: 2026
Title: Siddharth Kunte: Innovator in Cancer Prognostics
Introduction
Siddharth Kunte is a notable inventor based in Toledo, OH (US). He has made significant contributions to the field of medical imaging and cancer treatment. His work focuses on improving prognostic predictions for patients with hormone receptor-positive metastatic breast cancer.
Latest Patents
Siddharth Kunte holds a patent titled "Radiomic heterogeneity as prognostic predictor for treatment with CDK 4/6 inhibitors in hormone receptor-positive metastatic breast cancer." This patent describes a method for determining a prognostic outlook for patients undergoing treatment with cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors. The method involves analyzing imaging data to extract radiomic heterogeneity features, which serve as a prognostic marker for predicting patient responses to therapy.
Career Highlights
Throughout his career, Siddharth Kunte has worked with prestigious institutions, including Case Western Reserve University and the United States Government as represented by the Department of Veteran Affairs. His expertise in medical imaging and cancer research has positioned him as a valuable contributor to advancements in cancer treatment.
Collaborations
Siddharth has collaborated with notable professionals in his field, including Anant Madabhushi and Nathaniel Braman. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Siddharth Kunte's work in cancer prognostics exemplifies the intersection of technology and medicine. His innovative approach to predicting treatment responses has the potential to improve patient outcomes in metastatic breast cancer.